Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin

被引：33
|
作者：
Santamaría, A [1 ]
Sureda, A [1 ]
Martino, R [1 ]
Domingo-Albós, A [1 ]
Muñiz-Díaz, E [1 ]
Brunet, S [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Dept Hematol, Unitat Hematol Clin, Barcelona 08025, Spain
来源：
BONE MARROW TRANSPLANTATION | 1997年 / 20卷 / 12期
关键词：
ABO-incompatible BMT; erythropoietin; pure red cell aplasia;
D O I：
10.1038/sj.bmt.1701012
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
A 40-year-old woman with acute myeloid leukemia in first remission developed pure red cell aplasia after a T cell-depleted ABO-incompatible bone marrow transplant from her HLA-identical sister. She remained transfusion-dependent for 11 months despite conversion of the ABO blood group to donor type, and titers of anti-donor isohemagglutinin being undetectable. Treatment with erythropoietin resulted in rapid improvement of the anemia with no further need for transfusions up to 21 months post-transplant. This case suggests that erythropoietin may provide effective therapy for pure red cell aplasia after ABO-incompatible bone marrow transplantation without the additional risks of further immunosuppression.
引用
收藏
页码：1105 / 1107
页数：3
相关论文
共 50 条
  • [21] ANTILYMPHOCYTE GLOBULIN FOR TREATMENT OF PURE RED-CELL APLASIA AFTER MAJOR ABO INCOMPATIBLE MARROW TRANSPLANT
    LABAR, B
    BOGDANIC, V
    NEMET, D
    KOVACEVICMETELKO, J
    MRSIC, M
    PAVLETIC, Z
    ZUPANCICSALEK, S
    RADMAN, I
    AURER, I
    BONE MARROW TRANSPLANTATION, 1992, 10 (05) : 471 - 472
  • [22] Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant
    Vivero, Angelica
    Peedin, Alexis R. R.
    Gao, Yuanzheng
    Karp, Julie Katz
    JOURNAL OF CLINICAL APHERESIS, 2023, 38 (04) : 495 - 499
  • [23] Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation
    Bolan, CD
    Leitman, SF
    Griffith, LM
    Wesley, RA
    Procter, JL
    Stroncek, DF
    Barrett, AJ
    Childs, RW
    BLOOD, 2001, 98 (06) : 1687 - 1694
  • [24] Successful treatment with rituximab of pure red cell aplasia in allogeneic bone marrow transplant with major ABO mismatch
    Bazarbachi, A
    El Sayyad, M
    Baz, EMK
    BONE MARROW TRANSPLANTATION, 2006, 37 : S69 - S69
  • [25] Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation
    Khan, F.
    Linden, M. A.
    Zantek, N. D.
    Vercellotti, G. M.
    TRANSFUSION MEDICINE, 2014, 24 (03) : 187 - 188
  • [26] Treatment of Pure Red Cell Aplasia after Major ABO Incompatible Allogenic Stem Cell Transplantation: A French Retrospective Study
    Longval, Thomas
    Galimard, Jacques-Emmanuel
    Lepretre, Anne-Claire
    Suarez, Felipe
    Amiranoff, Denise
    Cazaux, Marine
    Michonneau, David
    Coman, Tereza
    Bourhis, Jean-Henri
    Quoc, Stephanie Nguyen
    Kaphan, Eleonore
    Socie, Gerard
    de Latour, Regis Peffault
    Resche-Rigon, Matthieu
    de Fontbrune, Flore Sicre
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 392 - 393
  • [27] Donor lymphocyte infusion as therapy for persistent pure red cell aplasia following major ABO-incompatible stem cell transplantation
    Lubking, A.
    Winqvist, I.
    Lenhoff, S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S373 - S373
  • [28] Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors
    Hirokawa, Makoto
    Fukuda, Takahiro
    Ohashi, Kazuteru
    Hidaka, Michihiro
    Ichinohe, Tatsuo
    Iwato, Koji
    Kanamori, Heiwa
    Murata, Makoto
    Sakura, Toru
    Imamura, Masahiro
    Adachi, Soichi
    Suzuki, Ritsuro
    Morishima, Yasuo
    Sakamaki, Hisashi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (07) : 1026 - 1032
  • [29] Anti-donor isoagglutinin reduction and pure red cell aplasia after major ABO-incompatible HSCT
    Stussi, G
    Bucheli, E
    Passweg, JR
    Halter, J
    Schanz, U
    Gmuer, J
    Gratwoh, LA
    Seebach, JD
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 43 - 43
  • [30] Pure Red Cell Aplasia is a Rare Complication after a Major ABO-Incompatible Transplant in a Single Asian Institution
    Lim, S. T.
    Thow, C. Y.
    Del Rosario, D. R.
    Tan, D.
    Tan, L.
    TRANSFUSION, 2015, 55 : 48A - 48A
12345